中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2014年
16期
77-78
,共2页
免疫球蛋白%乙肝疫苗%母婴阻断%临床疗效
免疫毬蛋白%乙肝疫苗%母嬰阻斷%臨床療效
면역구단백%을간역묘%모영조단%림상료효
Immunoglobulin%Hepatitis B vaccine%Mother-child interruption%Clinical efficacy
目的:探讨分析乙肝疫苗联合免疫球蛋白在乙肝母婴传播途径阻断中的作用效果。方法选取从2010年1月至2012年11月在我院进行产前检查的住院分娩的200例HBsAg阳性孕妇及脐血为研究对象,所有孕妇的肝功能均正常。按照平均随机抽样的原则平均分为对照组和干预组,各为100例孕妇。对照组的新生儿在出生后24 h内接种乙肝疫苗联合免疫球蛋白100IU;干预组的孕妇在孕周为28、32和36周时,分别注射200IU的免疫球蛋白各1次,其新生儿在出生后的处理与对照组相同。所有病例均进行成功随访,观察接种后12个月两组新生儿乙肝五项检查情况。结果干预组和对照组的12个月新生儿HBsAg和HBsAb阳性率分别为1%、94%和6%、75%,两组间的差异均有有统计学意义(P<0.05)。结论对新生儿肌内注射免疫球蛋白联合乙肝疫苗接种对乙肝母婴阻断中的作用效果显著,尤其是在分娩前进行免疫球蛋白产前干预具有良好的免疫阻断作用,降低了新生儿感染乙肝的概率安全有效,值得临床推广应用。
目的:探討分析乙肝疫苗聯閤免疫毬蛋白在乙肝母嬰傳播途徑阻斷中的作用效果。方法選取從2010年1月至2012年11月在我院進行產前檢查的住院分娩的200例HBsAg暘性孕婦及臍血為研究對象,所有孕婦的肝功能均正常。按照平均隨機抽樣的原則平均分為對照組和榦預組,各為100例孕婦。對照組的新生兒在齣生後24 h內接種乙肝疫苗聯閤免疫毬蛋白100IU;榦預組的孕婦在孕週為28、32和36週時,分彆註射200IU的免疫毬蛋白各1次,其新生兒在齣生後的處理與對照組相同。所有病例均進行成功隨訪,觀察接種後12箇月兩組新生兒乙肝五項檢查情況。結果榦預組和對照組的12箇月新生兒HBsAg和HBsAb暘性率分彆為1%、94%和6%、75%,兩組間的差異均有有統計學意義(P<0.05)。結論對新生兒肌內註射免疫毬蛋白聯閤乙肝疫苗接種對乙肝母嬰阻斷中的作用效果顯著,尤其是在分娩前進行免疫毬蛋白產前榦預具有良好的免疫阻斷作用,降低瞭新生兒感染乙肝的概率安全有效,值得臨床推廣應用。
목적:탐토분석을간역묘연합면역구단백재을간모영전파도경조단중적작용효과。방법선취종2010년1월지2012년11월재아원진행산전검사적주원분면적200례HBsAg양성잉부급제혈위연구대상,소유잉부적간공능균정상。안조평균수궤추양적원칙평균분위대조조화간예조,각위100례잉부。대조조적신생인재출생후24 h내접충을간역묘연합면역구단백100IU;간예조적잉부재잉주위28、32화36주시,분별주사200IU적면역구단백각1차,기신생인재출생후적처리여대조조상동。소유병례균진행성공수방,관찰접충후12개월량조신생인을간오항검사정황。결과간예조화대조조적12개월신생인HBsAg화HBsAb양성솔분별위1%、94%화6%、75%,량조간적차이균유유통계학의의(P<0.05)。결론대신생인기내주사면역구단백연합을간역묘접충대을간모영조단중적작용효과현저,우기시재분면전진행면역구단백산전간예구유량호적면역조단작용,강저료신생인감염을간적개솔안전유효,치득림상추엄응용。
Objective To explore the analysis of the effects of hepatitis B vaccine combined with immunoglobulin blocking the route of transmission of hepatitis B maternal and child. Methods Select from January 2010 to November 2012 in our hospital for prenatal care , hospital delivery of 200 HBsAg-positive pregnant women and umbilical cord blood were Studies . ALL pregnant women were normal liver function . In accordance with the principle of random sampling average average divided into control and intervention groups, each of 100 cases of pregnant women. Control group of newborns within 24 hours after birth dose of hepatitis B vaccine combined immunoglobulin 100IU;intervention group of pregnant women in gestational age was 28, 32 and 36 weeks, were injected immunoglobulin 200IU of all time, their newborns after birth the same with the control group. All cases were successful follow-up , 12 months, three groups of neonatal hepatitis B five checks observed after vaccination.Results Intervention group and the control group 12 months newborns of HBsAg and HBsAb positive rate of 1%, 94%and 6%, 75%, the difference between the two groups were statistically significant (P<0.05).Conclusion Hepatitis B vaccine and immunoglobulin combined effect of vaccination of hepatitis B in the interruption of hepatitis B transmission from mother to child significantly , with good the immune blocking effect , reducing the chance of newborns infected with hepatitis B , safe and effective, worthy of clinical application.